glp-1 drugs for insulin resistance can help you lose weight. They can't do this. A new American Heart Association statement, just published in JAMA, makes a point that doesn't get nearly enough attention in the Taking Mounjaro for Insulin Resistance

GLP-1 medications are becoming one of the most important workplace health and benefits topics

and in July 2024, the FDA approved Kisunla (donanemab) for early symptomatic Alzheimers, based on evidence of reduced clinical decline and a limitedduration regimen tied to amyloid plaque removal

Recent Findings Limited data are available regarding the changes in pharmacokinetics of drugs after bariatric surgery

Discover current prescription statistics, usage trends, patient demographics, and access patterns for GLP-1 receptor agonists in the US healthcare system.

Natural GLP1 plays a crucial role in regulating appetite, blood sugar, and overall metabolic health, yet many seek ways to enhance its levels without relying on medication

Berberine and GLP-1 are fundamentally different compounds targeting distinct metabolic pathways